Palisade Bio, Inc.
DE ˙ DB
SecurityDE:7NS0 / Palisade Bio, Inc.
InstitutionLPL Financial LLC
Latest Disclosed Ownership110,154 shares
Latest Disclosed Value $ 192,770
LPL Financial LLC reports 626.90% increase in ownership of 7NS0 / Palisade Bio, Inc.

On May 6, 2026 - LPL Financial LLC filed a 13F-HR form disclosing ownership of 110,154 shares of Palisade Bio, Inc. (DE:7NS0) valued at $192,770 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 15,154 shares of Palisade Bio, Inc.. This represents a change in shares of 626.90% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F PALISADE BIO COM 696389402 110,154 95,000 626.90 193 448.57 0.0001
2026-02-11 2025-12-31 13F PALISADE BIO COM 696389402 15,154 15,154 36 0.0000
2016-11-16 2016-09-30 13F NEURALSTEM COM 64127R302 0 -91,816 -100.00 0 -100.00
2016-08-15 2016-06-30 13F NEURALSTEM COM 64127R302 91,816 -106,306 -53.66 27 -80.85 0.0002
2016-05-16 2016-03-31 13F NEURALSTEM COM 64127R302 198,122 -9,100 -4.39 141 -34.72 0.0004
2016-02-12 2015-12-31 13F NEURALSTEM COM 64127R302 207,222 77,046 59.19 216 29.34 0.0006
2015-11-13 2015-09-30 13F NEURALSTEM COM 64127R302 130,176 -7,826 -5.67 167 -35.52 0.0009
2015-08-14 2015-06-30 13F NEURALSTEM COM 64127R302 138,002 3,790 2.82 259 4.44 0.0013
2015-05-14 2015-03-31 13F NEURALSTEM COM 64127R302 134,212 4,464 3.44 248 -29.75 0.0013
2015-02-13 2014-12-31 13F NEURALSTEM COM 64127R302 129,748 3,380 2.67 353 -10.41 0.0019
2014-11-10 2014-09-30 13F NEURALSTEM COM 64127R302 126,368 3,834 3.13 394 -23.79 0.0023
2014-08-05 2014-06-30 13F/A-1 NEURALSTEM COM 64127R302 122,534 51,668 72.91 517 74.07 0.0030
2014-08-05 2014-06-30 13F NEURALSTEM COM 64127R302 122,534 1,693
2014-05-12 2014-03-31 13F NEURALSTEM COM 64127R302 70,866 54,275 327.14 297 518.75 0.0018
2014-02-13 2013-12-31 13F NEURALSTEM COM 64127R302 16,591 -4,100 -19.82 48 -7.69 0.0003
2013-11-04 2013-09-30 13F NEURALSTEM COM 64127R302 20,691 4,300 26.23 52 116.67 0.0003
2013-08-15 2013-06-30 13F NEURALSTEM COM 64127R302 16,391 16,391 24 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.